Corey McCann, Pear Therapeutics CEO

The dig­i­tal health field con­tin­ues to boom as Soft­Bank-backed start­up hits uni­corn sta­tus in SPAC re­verse merg­er

Ed­i­tor’s note: In­ter­est­ed in fol­low­ing bio­phar­ma’s fast-paced IPO mar­ket? You can book­mark our IPO Track­er here.

At the in­ter­sec­tion of med­i­cine and cut­ting-edge tech­nol­o­gy, the broad field of dig­i­tal health has seen boom­ing val­u­a­tions in re­cent months with some big-name in­vestors jump­ing in. Now, a com­pa­ny work­ing on soft­ware-based ther­a­peu­tics has leaped to uni­corn sta­tus and will take its show on the road to Nas­daq.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.